Monitor for any future conversion of this 13G to a 13D, which would signal activist intent. The large warrant position with a blocker suggests potential future dilution management.
Price Chart
Executive Summary
GordonMD Global Investments LP and related entities filed an amended Schedule 13G disclosing beneficial ownership of 27,988,714 shares of Pyxis Oncology, Inc., representing 17.5% of outstanding common stock as of October 1, 2026. The stake includes 12,446,805 shares issuable upon exercise of warrants, subject to a 17.50% blocker that limits actual beneficial ownership. This is a passive investment filing with no change in control intent.
Key Financial Metrics
Key Facts
- GordonMD Global Investments LP and related entities beneficially own 27,988,714 shares of Pyxis Oncology common stock, representing 17.5% of outstanding shares.
- The stake includes 12,446,805 shares issuable upon exercise of warrants, subject to a 17.50% blocker limiting actual beneficial ownership.
- The filing is an amendment to Schedule 13G, indicating passive investment intent with no control-related activities.
- The reporting persons certify the securities were not acquired with the purpose of changing or influencing control of the issuer.
Financial Impact
GordonMD holds a 17.5% passive stake in Pyxis Oncology, valued based on current market price; no transaction amounts disclosed.
Risk Factors
- Warrant exercise could lead to dilution if the blocker is removed or exceeded.
- Passive filing status could change if GordonMD engages in activist activities.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000919574-26-006608 |
| Document: p15104195_ex-b.htm | 0000919574-26-006608 |
| Document: 0000919574-26-006608-index-headers.html | 0000919574-26-006608 |
| Document: 0000919574-26-006608-index.html | 0000919574-26-006608 |
| Document: 0000919574-26-006608.txt | 0000919574-26-006608 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Press Release | $1.66 | awaiting T+5 | — | $1.69 (+1.81%) |
Oct 21, 2026 6d ago | DEF 14A | $1.71 | awaiting T+5 | — | $1.69 (+1.17%) |
Oct 9, 2026 18d ago | SC 13G/A | $2.03 $1.68 | ▼ −17.24% | ▼ −15.27% | $1.69 (−16.75%) |
Oct 2, 2026 25d ago | SC 13G/A | $2.14 $2.03 | ▼ −5.14% | ▼ −6.30% | $1.69 (−21.03%) |
Oct 2, 2026 25d ago | Press Release | $2.14 $2.03 | ▲ +5.14% | ▲ +6.30% | $1.69 (+21.03%) |
Oct 1, 2026 26d ago | 8-K | $2.14 $2.03 | ▲ +5.14% | ▲ +6.30% | $1.69 (+21.03%) |
Oct 1, 2026 26d ago | 424B5 | $2.19 $1.99 | ▲ +9.13% | ▲ +10.43% | $1.69 (+22.83%) |
Sep 30, 2026 27d ago | Press Release | $2.33 $2.01 | ▲ +13.73% | ▲ +15.65% | $1.69 (+27.47%) |
Sep 9, 2026 6w ago | 8-K | $3.38 $3.34 | ▼ −1.18% | ▼ −0.09% | $1.69 (−50.00%) |
Sep 8, 2026 7w ago | 8-K | $3.89 $3.33 | ▼ −14.40% | ▼ −13.28% | $1.69 (−56.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers